Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China
· Delayed Price · Currency is CNY 29.34
-0.02 (-0.07%)
At close: Mar 9, 2026
SHE:002880 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,654 | 6,126 | 7,967 | 7,233 | 7,298 | 7,781 | Upgrade
|
| Market Cap Growth | 8.55% | -23.11% | 10.16% | -0.90% | -6.20% | 37.89% | Upgrade
|
| Enterprise Value | 7,294 | 6,434 | 8,271 | 7,256 | 7,063 | 7,397 | Upgrade
|
| Last Close Price | 29.34 | 26.83 | 34.64 | 31.27 | 31.31 | 33.21 | Upgrade
|
| PE Ratio | 29.10 | 24.16 | 36.44 | 61.55 | 35.53 | 40.87 | Upgrade
|
| Forward PE | 24.66 | 22.23 | 17.21 | 17.21 | 18.82 | - | Upgrade
|
| PS Ratio | 5.84 | 5.09 | 7.60 | 10.83 | 8.04 | 8.60 | Upgrade
|
| PB Ratio | 2.82 | 2.73 | 3.90 | 3.87 | 4.08 | 4.79 | Upgrade
|
| P/TBV Ratio | 3.09 | 2.98 | 4.29 | 4.14 | 4.36 | 5.17 | Upgrade
|
| P/FCF Ratio | - | - | 115.33 | - | 1204.41 | 67.80 | Upgrade
|
| P/OCF Ratio | 39.63 | 34.46 | 20.02 | 6032.03 | 29.56 | 25.60 | Upgrade
|
| EV/Sales Ratio | 6.40 | 5.35 | 7.89 | 10.86 | 7.78 | 8.18 | Upgrade
|
| EV/EBITDA Ratio | 17.07 | 14.64 | 25.20 | 40.17 | 25.15 | 29.53 | Upgrade
|
| EV/EBIT Ratio | 25.29 | 19.87 | 34.19 | 62.32 | 31.20 | 36.12 | Upgrade
|
| EV/FCF Ratio | -253.76 | - | 119.73 | - | 1165.53 | 64.45 | Upgrade
|
| Debt / Equity Ratio | 0.29 | 0.31 | 0.26 | 0.29 | 0.02 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 1.61 | 1.58 | 1.63 | 3.01 | 0.15 | 0.33 | Upgrade
|
| Debt / FCF Ratio | - | - | 7.77 | - | 7.17 | 0.72 | Upgrade
|
| Net Debt / Equity Ratio | 0.26 | 0.12 | 0.13 | 0.14 | -0.16 | -0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.42 | 0.61 | 0.80 | 1.40 | -1.03 | -1.55 | Upgrade
|
| Net Debt / FCF Ratio | -21.11 | -3.46 | 3.80 | -0.77 | -47.64 | -3.39 | Upgrade
|
| Asset Turnover | 0.35 | 0.39 | 0.39 | 0.29 | 0.47 | 0.53 | Upgrade
|
| Inventory Turnover | 0.75 | 0.95 | 0.96 | 0.83 | 1.33 | 1.33 | Upgrade
|
| Quick Ratio | 0.80 | 1.73 | 1.55 | 2.21 | 3.22 | 3.90 | Upgrade
|
| Current Ratio | 2.92 | 3.61 | 4.15 | 4.93 | 5.98 | 6.08 | Upgrade
|
| Return on Equity (ROE) | 10.12% | 11.84% | 11.12% | 6.63% | 12.02% | 12.34% | Upgrade
|
| Return on Assets (ROA) | 5.49% | 6.55% | 5.55% | 3.18% | 7.37% | 7.48% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.61% | 11.49% | 9.68% | 5.68% | 14.08% | 14.41% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.80% | 11.30% | 9.30% | 5.00% | 12.30% | 12.40% | Upgrade
|
| Earnings Yield | 3.44% | 4.14% | 2.74% | 1.63% | 2.81% | 2.45% | Upgrade
|
| FCF Yield | -0.43% | -1.27% | 0.87% | -4.51% | 0.08% | 1.47% | Upgrade
|
| Dividend Yield | 0.68% | 0.75% | 1.16% | - | 0.64% | 0.54% | Upgrade
|
| Payout Ratio | 29.48% | 25.99% | 30.00% | 49.09% | 20.36% | 18.74% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | -0.00% | -0.01% | 0.01% | -0.00% | -0.00% | Upgrade
|
| Total Shareholder Return | 0.66% | 0.74% | 1.15% | 0.01% | 0.64% | 0.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.